Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Response Inhibition”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01624142
What this trial is testing

Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders

Who this might be right for
Severe Familial Hypercholesterolemia
Amgen 300
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Not applicableStudy completedNCT05177146
What this trial is testing

Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression

Who this might be right for
Bipolar Disorder (BD)Suicidality
Centre for Addiction and Mental Health 16
Testing effectiveness (Phase 2)UnknownNCT03102723
What this trial is testing

Platelet Inhibition to Target Reperfusion Injury

Who this might be right for
STEMI
National Heart Centre Singapore 228
Testing effectiveness (Phase 2)WithdrawnNCT01269203
What this trial is testing

Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT04944173
What this trial is testing

SCION: SABR and Checkpoint Inhibition of NSCLC

Who this might be right for
Non Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNon-small Cell Lung Cancer Stage I+4 more
University of British Columbia
Testing effectiveness (Phase 2)Study completedNCT03065400
What this trial is testing

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

Who this might be right for
Chronic Phase MyelofibrosisPrimary MyelofibrosisPost-essential Thrombocythemia Myelofibrosis+1 more
John Mascarenhas 10
Testing effectiveness (Phase 2)Study completedNCT01638663
What this trial is testing

Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)

Who this might be right for
Cardiovascular DiseasesNephropathy
Regional Hospital Holstebro 20
Not applicableStudy completedNCT05900193
What this trial is testing

Sucralose and Lactisole Additions to OGTT in Humans

Who this might be right for
Neat OGTTOGTT With Added SucraloseOGTT With Added Lactisole
Rutgers, The State University of New Jersey 19
Not applicableNot Yet RecruitingNCT07784764
What this trial is testing

VST vs Modified Periosteal Inhibition Technique

Who this might be right for
Alveolar Bone Loss
Tanta University 42
Testing effectiveness (Phase 2)Looking for participantsNCT05470504
What this trial is testing

Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

Who this might be right for
Insulin Receptor MutationPartial Lipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Testing effectiveness (Phase 2)Study completedNCT04907214
What this trial is testing

SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot

Who this might be right for
ObesityPre-diabetes
Vanderbilt University Medical Center 29
Not applicableStudy completedNCT02414204
What this trial is testing

Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula

Who this might be right for
Improve Endothelial Function and Decrease Vascular Stenosis
University of Alabama at Birmingham 4
Early research (Phase 1)WithdrawnNCT04279938
What this trial is testing

A Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCL

Who this might be right for
Relapsed or Refractory Diffuse Large B-cell Lymphoma
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)Study completedNCT03110744
What this trial is testing

CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma

Who this might be right for
Chordoma
University Hospital Heidelberg 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07597902
What this trial is testing

SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction

Who this might be right for
Post-acute Sequelae of COVID-19Long COVID
Icahn School of Medicine at Mount Sinai 150
Not applicableNot Yet RecruitingNCT07599631
What this trial is testing

Integrated Neuromuscular Inhibition Technique Versus Instrument-Assisted Soft Tissue Mobilization On Neck Disability, Endurance, and Proprioception Of Nonspecific Chronic Neck Pain

Who this might be right for
Neck Pain
Cairo University 60
Early research (Phase 1)Study completedNCT04252339
What this trial is testing

RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor, Unspecified, Adult
Hoffmann-La Roche 56
Testing effectiveness (Phase 2)Study completedNCT01010737
What this trial is testing

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers

Who this might be right for
Influenza
BiondVax Pharmaceuticals ltd. 60
Not applicableStudy completedNCT05902819
What this trial is testing

Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories

Who this might be right for
Post-traumatic Stress DisorderCocaine Use Disorder
Psychiatric University Hospital, Zurich 138
Next Page